Inhibition of mutant FLT3 receptors in leukemia cells by the small molecule tyrosine kinase inhibitor PKC412
Open Access
- 1 June 2002
- journal article
- research article
- Published by Elsevier BV in Cancer Cell
- Vol. 1 (5), 433-443
- https://doi.org/10.1016/s1535-6108(02)00069-7
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignanciesBlood, 2001
- Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell linesOncogene, 2000
- Constitutive activation of FLT3 in acute myeloid leukaemia and its consequences for growth of 32D cellsBritish Journal of Haematology, 2000
- Tandem duplication of the FLT3 gene is found in acute lymphoblastic leukaemia as well as acute myeloid leukaemia but not in myelodysplastic syndrome or juvenile chronic myelogenous leukaemia in childrenBritish Journal of Haematology, 1999
- Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemiaLeukemia, 1999
- Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genesThe EMBO Journal, 1998
- Internal tandem duplication of FLT3 associated with leukocytosis in acute promyelocytic leukemiaLeukemia, 1997
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997
- Cell differentiation in acute myeloid leukemiaEuropean Journal of Haematology, 1996
- Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr/abl protein.Proceedings of the National Academy of Sciences of the United States of America, 1988